Abstract: Glycosaminoglycans (GAG), are extracellular matrix macromolecules that affect the phagocytic properties of macrophages. In order to assess whether the interaction between macrophages and Candida albicans (iCa) provokes changes in the phenotype, we analyzed the GAG profiles in two macrophage lines, ANA-1 (from murine bonemarrow) and BV-2 (from murine brain). We also investigated GAG modulation by interleukin-1␣ (IL-1␣) and interleukin-6 (IL-6). During iCa treatment and even after the addition of ILs, ANA-1 accumulated less total GAG compared to controls. IL-1 treatment, combined with iCa exposure, induced a decrease in heparan sulfate and chondroitin sulfate chains, and an increase in the hyaluronic acid percentage. IL-6 treatment, with or without iCa, decreased the hyaluronic acid/sulfated GAG ratio. The GAG pattern in BV-2 appears to be different to ANA-1 and iCa exposure does not induce any difference in total GAG. The inhibitory effect induced by ILs on GAG synthesis is less than that observed in ANA-1 and the GAG elution profile is modulated to a lesser extent by treatment with ILs and/or iCa compared to the ANA-1. We suggest that the observed changes in the expression of the individual GAG classes may be responsible for the macrophage functional heterogeneity. J. Leukoc. Biol. 64: 650-656; 1998.
INTRODUCTION
Macrophages belong to the mononuclear phagocyte system involved in many host defense functions such as the uptake and elimination of parasites, the processing and presentation of antigens to the immune system, and the destruction of transformed cells. Although deriving from a relatively homogenous population of precursor cells, their functional heterogeneity is determined on the basis of their capacity to secrete growth factors, depending on their developmental stage, and in particular due to a specific stimulus dictated by the microenvironment to which the macrophages are exposed. These stimuli induce transmembrane and intracellular signaling events leading to diversity in gene expression and in macrophage phenotype [1, 2] .
During inflammatory processes, the monocytes leave the circulation and migrate to the extravascular area where many cellular types (fibroblasts, neutrophils, lymphocytes, etc.) produce extracellular matrix (ECM) proteins. ECM is principally composed of proteoglycans (PG), which include sulfated and non-sulfated GAG such as hyaluronic acid (HA). Sulfated GAG such as chondroitin sulfate (CS), dermatan sulfate (DS), and heparan sulfate (HS) are in turn covalently attached to a core protein. The ECM not only serves a mechanical role in supporting and maintaining tissue structures, but also modulates a multitude of cell functions such as development and proliferation [3] , thus playing a critical role in the migration of macrophages to the target tissues or inflammatory foci. In fact, ECM components have been shown to interact with the cell surface molecules of leukocytes thus facilitating cell migration or proliferation [4] [5] [6] [7] . Laminin, an ECM molecule present at sites of immune and inflammatory responses, enhances complement and Fc-mediated phagocytosis in cultured human macrophages [8] [9] [10] ; fibronectin, another ECM glycoprotein, mediates microorganism uptake [11] ; HA has been shown to be a potent inhibitor of phagocytosis in vitro [12] . Macrophages possess receptors for ECM proteins, which affect the biochemical and functional profile of macrophages [13] , and are able to release numerous proteases that degrade ECM macromolecules [14] .
Quantitative or structural changes in ECM are often reflected in changes in the differentiation or functional state of cells because they have been shown to correlate to in vitro differentiation of monocytes into macrophages [15, 16] . Connective tissue proteins and phagocyte cell functions are thus strictly related.
Furthermore, ECM is a complex and dynamic reservoir of cytokines that regulate or modify cellular responses in inflammatory and immune reactions inducing biological responses by binding to specific cell surface receptors [17] . It has been shown that the in vitro exposure of human monocytes and monocyte-derived macrophages to microbial infections induces the release of proinflammatory cytokines such as interleukin-1 (IL-1) and interleukin-6 (IL-6) [18] .
In previous studies we showed that macrophages, treated with HA or CS, underwent changes in shape and in the organization of the cytoskeleton and modified their adhesion to the substrate [19, 20] . The internalization of Candida albicans, evaluated as cell-associated radioactivity, diminished after HA or HS administration, whereas CS had no effects. Our results therefore show a relationship between the macrophage phenotype and phagocytic functions and a role of GAG as modulators of these functions.
To gain a better understanding of the relationship between ECM components and macrophage functional heterogeneity, we studied GAG profile of macrophages of different anatomical origin, bone marrow-(ANA-1) and brain-derived (BV-2) macrophages. Both cell lines were exposed or not to C. albicans and cultured in the presence of the two modulators of phagocytic processes, IL-1␣ and IL-6.
MATERIALS AND METHODS

Cell cultures
The bone marrow-derived macrophage cell line ANA-1 and brain-derived BV2 macrophages were obtained from C57/BL6 mice by immortalization with a recombinant retrovirus carrying the v-raf/v-myc oncogenes as previously described [21, 22] . Cells were seeded in 1.75-mm-diameter Petri dishes at a concentration of 10 6 cells/mL and cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), glutamine 2 mM, antibiotics in a humidified atmosphere of 5% CO 2 at 37°C.
Newly synthesized GAG isolation and identification
For the biosynthetic labeling of GAG, ANA-1 and BV2 macrophage cells were incubated for 6 and 48 h in RPMI 1640 medium ϩ 10% FCS and exposed to [ 3 H]glucosamine (25 µCi/mL; 28 Ci/mmol, Amersham) in the last 6 h of culture.
In a parallel set of experiments, macrophages were maintained for 30 h in RPMI 1640 ϩ 10% FCS with and without IL-1␣ or IL-6 (human recombinant, Boehringer Mannheim) both at doses of 5 U/mL. Candida albicans, heat inactivated for 30 min (iCa), ratio 1:5 compared to macrophages and [ 3 H]glucosamine (25 µCi/mL), was added in the last 6 h of culture. At the end of the incubation times, cells and media were recovered separately. Cells were scraped in 1 mL ice-cold 0.01 M Tris-HCl and 1.5 mM CaCl 2 (pH 7.5) and lysed by sonicating (amplitude 18) with six 10-s bursts using a B15P model Branson sonicator. Media were dialyzed, lyophilized, and dissolved in the above buffer. Lysates and media were boiled for 5 min and then digested for 3 days at 37°C with 1 mg/mL predigested (for 30 min at 37°C) protease type XIV (Sigma Chemical Co., St. Louis, MO) in the presence of 1% toluene. Fresh protease was added daily. Proteins in the digested samples were precipitated with 10% trichloroacetic acid (TCA), pelleted by centrifugation (12,000 rpm), and discarded. GAG were precipitated from recovered supernatants with 3 volumes of 5% potassium acetate in absolute ethanol in the presence of 100 µg of GAG carrier and pelleted by centrifugation for 20 min at 12,000 rpm. GAG were dissolved in 0.1 M Tris-HCl pH 7.2 and aliquots of [ 3 H]GAG were mixed with 3 mL of Ultima Gold (Canberra Packard Int. S.A., Zurich, Switzerland) and counted in a Packard Tri-Carb 2425 liquid scintillation counter.
Aliquots of media containing [ 3 H]GAG were applied to a DE-52 cellulose anion exchange column (0.5 ϫ 6 cm), equilibrated with 10 mM Tris-HCl (pH 7.2) and eluted at room temperature with increasing stepwise concentrations of NaCl (0.1, 0.3, 0.4, 0.5, 0.6 M). One-milliliter fractions were collected; 0.2-mL aliquots were mixed with 3 mL of Ultima Gold and counted in a liquid scintillation counter. Column fractions corresponding to specific types of GAG were pooled, dialyzed, and lyophilized. Standard GAG (Sigma) were then added and precipitated with 3 volumes of 5% potassium acetate in ethanol. Radioactivity was measured in both supernatants (digested GAG) and pellet (undigested GAG).
Individual GAG were identified by their susceptibility to specific enzymes. Testicular hyaluronate lyase (beef, Miles Italiana, S.P.A., Cavenago Brianza, Milano, Italy) and streptomyces hyaluronate lyase (Streptomyces hyaluroniticus, Seikagaku Kogyo Co.) digestions were performed by dissolving lyophilized samples in 0.02 M sodium acetate buffer, pH 5, containing 0.1 M NaCl, at 37°C for 24 h with 30 and 5 enzyme units, respectively. Chondroitin AC-II lyase (Arthrobacter aurescens, Seikagaku Kogyo Co.) digestions were performed in 0.01 M Tris buffer, pH 8, at 25°C for 24 h with 0.5 and 0.01 enzyme units. Nitrous acid was used to degrade heparan sulfate. Recovery of the fractionating procedure was about 85-95%. Results are expressed as cpm/mg of protein [23] . (Fig. 1) . It is noteworthy that neosynthesized GAG were retained more in the cellular compartment. The radioactivity assayed in the medium was about half of that present in the cell pellet. The radioactivity of both cellular and extracellular GAG increased approximately linearly across the incubation times. After 6 h of culture the amount of cellular GAG from BV-2 cell line was higher compared to the ANA-1 line (Fig. 1A) . On the other hand, after 48 h of culture the amount of endocellular GAG in the ANA-1 cells was significantly higher than that in the BV-2 cells. As far as the GAG secreted in the medium is concerned (Fig. 1B) , the results demonstrate that after 36/48 h, the macrophages of the ANA-1 line secreted significantly more GAG compared to the macrophages of the BV-2 line. Therefore on the whole the macrophages of the ANA-1 line in culture produce a greater quantity of total GAG compared to that produced by the BV-2 line (Fig. 1C) .
Statistical analysis
Composition of labeled secreted GAG
Ionic exchange chromatography demonstrated the presence of five classes of secreted GAG, namely hyaluronic acid (HA), chondroitin (Ch), heparan sulfate (HS), chondroitin sulfate (CS), and dermatan sulfate (DS; Fig. 2) . In both macrophage populations, after 6 h HA was the dominant GAG and HS and CS represented about 50% of the HA. After 48 h of maintenance in vitro, the ANA-1 macrophages produce a lower quantity of HA compared to that produced by the BV-2 macrophages. In both cell lines it was seen that increasing the in vitro maintenance time from 6 to 48 h, the HA/sulfated GAG ratio shifted in favor of the latter.
GAG synthesis and profile in IL-1-or IL-6-treated ANA-1 and BV-2 macrophages during iCa exposition Both IL-1 and IL-6 treatment of ANA-1 macrophages reduced cellular and extracellular GAG; the inhibition effect on secreted GAG was seen to a greater extent with IL-6 (decrease of 78% for IL-6, decrease of 61% for IL-1; Table 1 ). ANA-1 macrophages exposed to iCa had a lower GAG content compared to the controls both in the cellular (decrease of 25%) and extracellular compartment (decrease of 36%). Therefore, the inhibitory effect induced by iCa on the intra-and extracellular GAG quota was less than that induced by the two cytokines. Treatment of BV-2 macrophages with IL-1 also induces a reduction in GAG, but the effect is limited to the intracellular compartment (decrease of 35%, data not shown). Exposure of BV-2 to iCa alone or in combination with IL-1 does not show any modifications in the total GAG. In the presence or absence of iCa, IL-6 induces a significant reduction both of the GAG accumulated in the cells and the secreted GAG (decrease of 27 and 21%, respectively, data not shown).
Analysis of individual secreted GAG classes secreted by ANA-1 macrophages (Fig. 3 and Table 2 ) showed that IL-1 addition induced an increase of the percentage of HA (more than double) and a decrease of HS and CS with an increase of the HA/sulfated GAG. In iCa-treated macrophages, the HA percentage was moderately enhanced compared to the controls; the radioactivity incorporated into HS and CS was significantly reduced, whereas the percentage of DS was about fourfold above the controls. After combined treatment with iCa and IL-1, the percentage of HA increased, as also seen following treatment with iCa alone. A further decrease in HS and a more significant increase in DS percentage were seen. IL-6 treatment induced a slight increase in the percentage of HA and HS, a considerable increase in DS, and a sharp decrease in CS. The HA/sulfated GAG ratio was in favor of sulfated GAG. Combined treatment with IL-6 and iCa produced an increase in the HS percentage.
In BV-2, treatment with IL-1 or IL-6 induced fewer modifications in redistribution of the percentage of individual GAG classes (Table  2 ). In fact both the ILs determine only a slight decline in the HA and a modest increase in the CS. The most significant event during exposure to iCa is the increase in the HS percentage.
DISCUSSION
Relatively little is known concerning the relationship among ECM components and cells of the immune system. Neverthe- ANA-1 macrophages were maintained in RPMI 1640 ϩ 10% FCS for 30 h with or without IL-1␣ or IL-6 (both at the dose of 5 U/mL). [ 3 H]glucosamine (25 µCi/mL) and iCa (heat inactivated for 30 min, ratio 1:5) were added in the last 6 h and processed as described in Materials and Methods. [ 3 H]glucosamine incorporation was evaluated into cellular and extracellular GAG. Values are expressed as cpm/mg protein and represent the mean Ϯ SD for four determinations from a typical experiment. Similar results were seen in three independent experiments. Differences versus each control are significant for a P Ͻ 0.001, b P Ͻ 0.01, c P Ͻ 0.05, d not significant. less, it is well-known that the interactions between monocytes and ECM proteins represent an important stimulus for differentiation of macrophages [24] [25] [26] . ECM macromolecules, generated at inflammatory sites, affect macrophage adherence, phagocytosis, and local cytokine production. Various hypotheses have been put forward regarding the mechanisms by which the ECM components influence phagocytosis. These hypotheses include the following: a direct effect on the number of ECM surface receptors, a change in the receptor typology, an effective link between receptors and cytoskeletal components affecting in turn the endocytosis vesicles. [19, 20, 27, 28] .
This study was conducted in two macrophage cell lines obtained from different anatomical areas with different functional and secretory activities [29] [30] [31] . Previous studies showed that the two cell lines actively phagocytize Candida, although macrophages of microglial origin were the most effective [31, 32] . We have now shown that in ANA-1 and BV-2 macrophages, the biosynthetic program for GAG is different, since each cell line exhibited a peculiar GAG pattern, modulated by IL-1␣ and IL-6 treatment and further altered after exposition to a phagocytic stimulus. In ANA-1, more than in BV-2, total GAG synthesis is greatly inhibited by treatment with IL-1␣ and IL-6. In both macrophage populations, iCa exposure tends partially or completely to remove the strong inhibitory effect induced by ILs.
Chromatographic analysis of the media showed that ILs have a greater modulating effect on the ANA-1 line than on BV-2. In ANA-1, in fact, IL-1␣ treatment decreases the quota of sulfated GAG, in particular shifting the HA/sulfated GAG ratio in favor of HA. This ratio is modified during iCa exposure or after treatment with IL-6 and/or iCa. BV-2 reveals a different phenotype compared to ANA-1 with increased production of HA. Exposure to iCa lowers the HA/GAG sulfated ratio inducing a relative increase in HS, whereas the ILs induce a modest modification in the expression of individual GAG classes. On the whole the results prove that since ANA-1 and BV-2 come from different anatomical sites, they each have particular GAG patterns and respond differently to treatment with the cytokines. These data may have functional implications. In fact macrophages bind HA and possess HA receptors, as well as being able to degrade HA [33] [34] [35] . HA, in its turn, reduces IL-1-stimulated proteoglycan degradation [36] . The altered balance between HA amount and sulfated GAG during iCa and IL treatment may be important during the process of migration of macrophages through the ECM and represents a critical aspect of phagocytic functions [37] .
Cytokines show selective and differential binding to glycosaminoglycans or core protein of proteoglycans [38] . IL-1␤ partially binds to hyaluronic acid, whereas IL-1␣ shows essentially no retention. Selective, partial binding to acidic polysaccharides is also exhibited by IL-6, which binds heparin, dextran sulfate, and dermatan sulfate but is poorly retained on chondroitin sulfate [39, 40] .
Furthermore, a cascade control of cytokine production has been indicated [41] [42] [43] , as well as the role of cytokines in host defense [44] [45] [46] . Cytokines secreted by macrophages greatly influence, in an autocrine manner, the ability of macrophages to defend against microbial challenge [47] . The up-regulation of IL-1␣ and the down-regulation of IL-6 due to changes in IL-1 and/or HA amounts might broadly affect aspects of the delicate balance of the cytokine network during immunity response.
Furthermore we, like others [48] [49] [50] [51] [52] , have shown that macrophage-derived growth factors are able to modulate the function of normal and pathological fibroblasts affecting collagen and GAG synthesis and driving the fibro-proliferative responses. Therefore, ECM components become the modulatory signals of a microenvironment, where they modulate the genetic program and control the cytokine release responsible for the fibrotic processes of many connective disorders.
In conclusion, our results provide the first evidence that GAG profile of macrophages is modulated by incubation with IL-1, IL-6, or iCa, suggesting a close relationship between GAG-sulfated and non-sulfated composition and release, IL production, and macrophage functions. Further studies are necessary to verify the mechanism through which the composition in the individual GAG classes constitutes an important means of metabolic control of the different macrophage functions.
